Viewing Study NCT04156659


Ignite Creation Date: 2025-12-24 @ 2:28 PM
Ignite Modification Date: 2026-02-25 @ 11:48 PM
Study NCT ID: NCT04156659
Status: WITHDRAWN
Last Update Posted: 2023-03-09
First Post: 2019-10-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Tisagenlecleucel in Chinese Pediatric and Young Adult Subjects With Relapsed or Refractory B-cell ALL
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module